Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 750 clinical trials
featured
12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

  • 424 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

  • 182 views
  • 08 Nov, 2020
  • 1 location
featured
If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.

If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.

  • 212 views
  • 23 Nov, 2020
  • 1 location
featured
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study

This study will help us learn more about a study drug called galcanezumab. We are testing this study drug to find out if it is safe and effective at helping adolescents who have chronic migraine headaches.

migraine in children
chronic migraine
migraine
  • 0 views
  • 27 Jan, 2021
  • 1 location
featured
Allergic Contact Dermatitis study for 12-54 years of age

Have you been suffering with Allergic Contact Dermatitis (skin rash, hives, etc.) We have a new trial opening for children and adults who have been diagnosed with moderate to severe Allergic Contact Dermatitis. A free evaluation is available to see if you qualify.  

allergic contact dermatitis
  • 273 views
  • 05 Jun, 2020
  • 1 location
featured
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED

A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED

  • 522 views
  • 08 Nov, 2020
  • 1 location
featured
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis

  • 372 views
  • 23 Nov, 2020
  • 1 location
featured
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

advanced lung cancer
lung metastases
refractory non-small cell lung cancer
recurrent non-small cell lung cancer
metastatic non-small cell lung cancer
  • 0 views
  • 18 Feb, 2021
  • 4 locations
featured
Do You Have Osteoporosis?

Do You Have Osteoporosis?

  • 1122 views
  • 08 Nov, 2020
  • 1 location
featured
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder

Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder

  • 732 views
  • 23 Nov, 2020
  • 1 location